Bacterium and Viral Coinfection Contributes to Postinfectious Hydrocephalus
By LabMedica International staff writers Posted on 12 Oct 2020 |

Image: Yellow color shows thiamine degradation on an agar plate of cultured Paenibacillus thiaminolyticus (Photo courtesy of Catherine A. Richter, PhD).
Neonatal sepsis often precedes postinfectious hydrocephalus (PIH), although the manifestations of hydrocephalus typically emerge in the months after the neonatal period as sufficient cerebrospinal fluid (CSF) accumulates such that cranial expansion garners medical attention.
Postinfectious hydrocephalus (PIH), is the most common cause of pediatric hydrocephalus worldwide, yet the microbial pathogens underlying this disease remain to be elucidated. Of the estimated 400,000 new cases each year, about half are estimated to be postinfectious, with the largest number of cases in low- and middle-income countries, especially sub-Saharan Africa.
A team of international scientists collaborating with the Columbia University's Mailman School of Public Health (New York, NY, USA) analyzed samples from 100 patients, 64 with post-infectious hydrocephalus (PIH) and 36 with non-post-infectious hydrocephalus (NPIH), all of whom were less than three months old who were seen at the CURE Children's Hospital of Uganda (Mbale, Uganda)
Blood was sampled with aseptic technique at the time of surgery, either at the time of catheter placement for an intravenous line or during venipuncture for routine laboratory testing. Cerebrospinal fluid (CSF) was obtained at the time of initial surgery. The team used both Sanger-based sequencing of bacterial 16S ribosomal DNA V1-V4 regions and next-generation sequencing of the V1-V2 and V4 regions. A broad screen for viral presence was performed in two different ways: VirCapSeq oligomer concentration and total RNA sequencing analysis. For the viruses that appeared abundant in either PIH or NPIH, polymerase chain reaction (PCR) confirmation was performed.
Using a targeted viral detection capture approach called VirCapSeqVERT, the investigators uncovered 11 viral strains across slightly more than a third of CSF samples. Cytomegalovirus was found among a portion of post-infectious hydrocephalus patients' CSF samples, but not among non-post-infectious hydrocephalus patients. Cytomegalovirus is a common virus that typically causes minor symptoms in adults but may lead to neurological damage in infants who acquire it early in life. The team grew three Paenibacillus isolates in culture and used whole-genome sequencing analysis to identify them as P. thiaminolyticus. V1-V4 Sanger sequencing of subcloned amplicons identified Paenibacillus as a predominant organism within the PIH cohort (23 of 64), but not within the NPIH cohort (0 of 36). A hybrid method was used to reconstruct the genome of a P. thiaminolyticus isolate, combining short-read sequencing, optical mapping (Bionano Genomics, San Diego, CA, USA), and nanopore long contiguous sequencing (MinION, Oxford Nanopore Technologies, Oxford, UK).
The authors concluded that their findings showed that an unbiased pan-microbial approach enabled characterization of Paenibacillus in CSF samples from PIH cases, and point toward a pathway of more optimal treatment and prevention for PIH and other proximate neonatal infections.
Edith Mbabazi-Kabachelor, MD, MPH, director of research at CURE Children's Hospital of Uganda and a co-author of the study, said, “Hydrocephalus is the most common childhood neurosurgical condition that we see in the population that we serve. If hydrocephalus is left untreated in children less than two years old, the progressive increase in head size will lead to further brain damage, resulting in the majority of these children dying, and those that survive being left with severe cognitive and physical disability.” The study was published on September 30, 2020 in the journal Science Translational Medicine.
Related Links:
Columbia University's Mailman School of Public Health
CURE Children's Hospital of Uganda
Bionano Genomics
Oxford Nanopore Technologies
Postinfectious hydrocephalus (PIH), is the most common cause of pediatric hydrocephalus worldwide, yet the microbial pathogens underlying this disease remain to be elucidated. Of the estimated 400,000 new cases each year, about half are estimated to be postinfectious, with the largest number of cases in low- and middle-income countries, especially sub-Saharan Africa.
A team of international scientists collaborating with the Columbia University's Mailman School of Public Health (New York, NY, USA) analyzed samples from 100 patients, 64 with post-infectious hydrocephalus (PIH) and 36 with non-post-infectious hydrocephalus (NPIH), all of whom were less than three months old who were seen at the CURE Children's Hospital of Uganda (Mbale, Uganda)
Blood was sampled with aseptic technique at the time of surgery, either at the time of catheter placement for an intravenous line or during venipuncture for routine laboratory testing. Cerebrospinal fluid (CSF) was obtained at the time of initial surgery. The team used both Sanger-based sequencing of bacterial 16S ribosomal DNA V1-V4 regions and next-generation sequencing of the V1-V2 and V4 regions. A broad screen for viral presence was performed in two different ways: VirCapSeq oligomer concentration and total RNA sequencing analysis. For the viruses that appeared abundant in either PIH or NPIH, polymerase chain reaction (PCR) confirmation was performed.
Using a targeted viral detection capture approach called VirCapSeqVERT, the investigators uncovered 11 viral strains across slightly more than a third of CSF samples. Cytomegalovirus was found among a portion of post-infectious hydrocephalus patients' CSF samples, but not among non-post-infectious hydrocephalus patients. Cytomegalovirus is a common virus that typically causes minor symptoms in adults but may lead to neurological damage in infants who acquire it early in life. The team grew three Paenibacillus isolates in culture and used whole-genome sequencing analysis to identify them as P. thiaminolyticus. V1-V4 Sanger sequencing of subcloned amplicons identified Paenibacillus as a predominant organism within the PIH cohort (23 of 64), but not within the NPIH cohort (0 of 36). A hybrid method was used to reconstruct the genome of a P. thiaminolyticus isolate, combining short-read sequencing, optical mapping (Bionano Genomics, San Diego, CA, USA), and nanopore long contiguous sequencing (MinION, Oxford Nanopore Technologies, Oxford, UK).
The authors concluded that their findings showed that an unbiased pan-microbial approach enabled characterization of Paenibacillus in CSF samples from PIH cases, and point toward a pathway of more optimal treatment and prevention for PIH and other proximate neonatal infections.
Edith Mbabazi-Kabachelor, MD, MPH, director of research at CURE Children's Hospital of Uganda and a co-author of the study, said, “Hydrocephalus is the most common childhood neurosurgical condition that we see in the population that we serve. If hydrocephalus is left untreated in children less than two years old, the progressive increase in head size will lead to further brain damage, resulting in the majority of these children dying, and those that survive being left with severe cognitive and physical disability.” The study was published on September 30, 2020 in the journal Science Translational Medicine.
Related Links:
Columbia University's Mailman School of Public Health
CURE Children's Hospital of Uganda
Bionano Genomics
Oxford Nanopore Technologies
Latest Microbiology News
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
New Blood Test for Leukemia Risk Detection Could Replace Bone Marrow Sampling
Myelodysplastic syndrome (MDS) is a condition typically associated with aging, where blood stem cells fail to develop into fully functional blood cells. Early and accurate diagnosis is vital, as MDS can... Read more
Blood Test Detects Preeclampsia Risk Months Before Symptoms Appear
Preeclampsia, a pregnancy-related complication characterized by elevated blood pressure and organ dysfunction, remains a major contributor to maternal and infant health issues globally. Existing screening... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more